StockData
ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW

Aclarion, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.89+0.04 (+2.16%)

Close on Oct 19, 2026

Market cap
$4.65M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2023
Ended Dec 31, 2023
Feb 21, 2024During market hours–––
Q2 FY2023
Ended Jun 30, 2023
Aug 25, 2023During market hours–––
Q1 FY2023
Ended Mar 31, 2023
May 16, 2023During market hours–––

Press releases

Announcements Aclarion filed with the SEC